Nonviral siRNA delivery systems for pancreatic cancer therapy

S Aghamiri, P Raee, S Talaei… - Biotechnology and …, 2021 - Wiley Online Library
The serious drawbacks of the conventional treatment of pancreatic ductal adenocarcinoma
(PDAC) such as nonspecific toxicity and high resistance to chemo and radiation therapy …
被引用次数：18 相关文章

Nonviral siRNA delivery systems for pancreatic cancer therapy

S Aghamiri, P Raee, S Talaei… - Biotechnology and …, 2021 - Wiley Online Library
The serious drawbacks of the conventional treatment of pancreatic ductal adenocarcinoma
(PDAC) such as nonspecific toxicity and high resistance to chemo and radiation therapy …

Nonviral siRNA delivery systems for pancreatic cancer therapy.

S Aghamiri, P Raee, S Talaei… - Biotechnology and …, 2021 - europepmc.org
The serious drawbacks of the conventional treatment of pancreatic ductal adenocarcinoma
(PDAC) such as nonspecific toxicity and high resistance to chemo and radiation therapy …

Nonviral siRNA delivery systems for pancreatic cancer therapy

S Aghamiri, P Raee, S Talaei… - Biotechnology and …, 2021 - pubmed.ncbi.nlm.nih.gov
The serious drawbacks of the conventional treatment of pancreatic ductal adenocarcinoma
(PDAC) such as nonspecific toxicity and high resistance to chemo and radiation therapy …